260 related articles for article (PubMed ID: 23978400)
41. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
[TBL] [Abstract][Full Text] [Related]
42. TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.
Jianwei Z; Qi L; Quanquan X; Tianen W; Qingwei W
Pathol Oncol Res; 2018 Apr; 24(2):251-257. PubMed ID: 28466252
[TBL] [Abstract][Full Text] [Related]
43. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
Nguyen DH; Catling AD; Webb DJ; Sankovic M; Walker LA; Somlyo AV; Weber MJ; Gonias SL
J Cell Biol; 1999 Jul; 146(1):149-64. PubMed ID: 10402467
[TBL] [Abstract][Full Text] [Related]
44. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
45. RhoB regulates uPAR signalling.
Alfano D; Ragno P; Stoppelli MP; Ridley AJ
J Cell Sci; 2012 May; 125(Pt 10):2369-80. PubMed ID: 22366462
[TBL] [Abstract][Full Text] [Related]
46. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
[TBL] [Abstract][Full Text] [Related]
47. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
48. jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells.
Pontrelli P; Ranieri E; Ursi M; Ghosh-Choudhury G; Gesualdo L; Paolo Schena F; Grandaliano G
Kidney Int; 2004 Jun; 65(6):2249-61. PubMed ID: 15149338
[TBL] [Abstract][Full Text] [Related]
49. Cadmium induces urokinase-type plasminogen activator receptor expression and the cell invasiveness of human gastric cancer cells via the ERK-1/2, NF-κB, and AP-1 signaling pathways.
Khoi PN; Xia Y; Lian S; Kim HD; Kim DH; Joo YE; Chay KO; Kim KK; Jung YD
Int J Oncol; 2014 Oct; 45(4):1760-8. PubMed ID: 25069788
[TBL] [Abstract][Full Text] [Related]
50. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
Benasciutti E; Pagès G; Kenzior O; Folk W; Blasi F; Crippa MP
Blood; 2004 Jul; 104(1):256-62. PubMed ID: 15031204
[TBL] [Abstract][Full Text] [Related]
51. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
[TBL] [Abstract][Full Text] [Related]
52. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling.
Lin CH; Lin HH; Kuo CY; Kao SH
Oncotarget; 2017 Feb; 8(7):11316-11328. PubMed ID: 28076322
[TBL] [Abstract][Full Text] [Related]
53. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
54. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
Alfano D; Iaccarino I; Stoppelli MP
J Biol Chem; 2006 Jun; 281(26):17758-67. PubMed ID: 16632475
[TBL] [Abstract][Full Text] [Related]
55. TMPRSS4: an emerging potential therapeutic target in cancer.
de Aberasturi AL; Calvo A
Br J Cancer; 2015 Jan; 112(1):4-8. PubMed ID: 25203520
[TBL] [Abstract][Full Text] [Related]
56. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling.
Jin J; Shen X; Chen L; Bao LW; Zhu LM
Biomed Pharmacother; 2016 Feb; 77():30-6. PubMed ID: 26796262
[TBL] [Abstract][Full Text] [Related]
57. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility.
Nguyen DH; Hussaini IM; Gonias SL
J Biol Chem; 1998 Apr; 273(14):8502-7. PubMed ID: 9525964
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
Bilsland AE; Stevenson K; Atkinson S; Kolch W; Keith WN
Cancer Res; 2006 Feb; 66(3):1363-70. PubMed ID: 16452190
[TBL] [Abstract][Full Text] [Related]
60. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
Santibanez JF; Krstic J
Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
